

Your fight against
gastroesophageal cancer
may start or continue here
OPDIVO, alone or in combination with chemotherapy or YERVOY® (ipilimumab), is an FDA-approved immunotherapy for esophageal, gastroesophageal junction, and advanced gastric cancers